BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 38627815)

  • 1. Systemic treatment of mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer-single versus double checkpoint inhibition.
    Marinelli D; Sabatini A; Bengala E; Ciurluini F; Picone V; Santini D; Pietrantonio F; Rossini D; Cremolini C
    ESMO Open; 2024 Jun; 9(6):103483. PubMed ID: 38833965
    [No Abstract]   [Full Text] [Related]  

  • 2. Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells.
    Zhong P; Nakata K; Oyama K; Higashijima N; Sagara A; Date S; Luo H; Hayashi M; Kubo A; Wu C; He S; Yamamoto T; Koikawa K; Iwamoto C; Abe T; Ikenaga N; Ohuchida K; Morisaki T; Oda Y; Kuba K; Nakamura M
    J Exp Clin Cancer Res; 2024 May; 43(1):138. PubMed ID: 38715057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling YWHAH: A potential therapeutic target for overcoming CD8
    Li Q; Yuan Z; Wang Y; Zhai P; Wang J; Zhang C; Shao Z; Xing C
    Int Immunopharmacol; 2024 Jun; 135():112317. PubMed ID: 38796965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PACSIN1 promotes immunosuppression in gastric cancer by degrading MHC-I.
    Liu Z; Li X; Muhammad A; Sun Q; Zhang Q; Wang Y; Wang Y; Ren J; Wang D
    Acta Biochim Biophys Sin (Shanghai); 2024 Jun; ():. PubMed ID: 38826133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shaping immune landscape of colorectal cancer by cholesterol metabolites.
    Bai Y; Li T; Wang Q; You W; Yang H; Xu X; Li Z; Zhang Y; Yan C; Yang L; Qiu J; Liu Y; Chen S; Wang D; Huang B; Liu K; Song BL; Wang Z; Li K; Liu X; Wang G; Yang W; Chen J; Hao P; Zhang Z; Wang Z; Zhu ZJ; Xu C
    EMBO Mol Med; 2024 Feb; 16(2):334-360. PubMed ID: 38177537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stat3-mediated Atg7 expression enhances anti-tumor immunity in melanoma.
    Zimmerman SM; Suh E; Smith SR; Souroullas GP
    bioRxiv; 2024 Jun; ():. PubMed ID: 38915518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer.
    Pecci F; Cantini L; Bittoni A; Lenci E; Lupi A; Crocetti S; Giglio E; Giampieri R; Berardi R
    Curr Treat Options Oncol; 2021 Jun; 22(8):69. PubMed ID: 34110510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of autophagy-related protein 7 enhances anti-tumor immune response and improves efficacy of immune checkpoint blockade in microsatellite instability colorectal cancer.
    Zhang W; Chen L; Liu J; Chen B; Shi H; Chen H; Qi H; Wu Z; Mao X; Wang X; Huang Y; Li J; Yu Z; Zhong M; Wang T; Li Q
    J Exp Clin Cancer Res; 2024 Apr; 43(1):114. PubMed ID: 38627815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022.
    André T; Cohen R; Salem ME
    Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-9. PubMed ID: 35471834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape.
    Glaire MA; Ryan NA; Ijsselsteijn ME; Kedzierska K; Obolenski S; Ali R; Crosbie EJ; Bosse T; de Miranda NF; Church DN
    J Pathol; 2022 Jul; 257(3):340-351. PubMed ID: 35262923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A TGFβ-Dependent Stromal Subset Underlies Immune Checkpoint Inhibitor Efficacy in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Colorectal Cancer.
    Endo E; Okayama H; Saito K; Nakajima S; Yamada L; Ujiie D; Kase K; Fujita S; Endo H; Sakamoto W; Saito M; Saze Z; Momma T; Ohki S; Mimura K; Kono K
    Mol Cancer Res; 2020 Sep; 18(9):1402-1413. PubMed ID: 32493700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment.
    Taieb J; Svrcek M; Cohen R; Basile D; Tougeron D; Phelip JM
    Eur J Cancer; 2022 Nov; 175():136-157. PubMed ID: 36115290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer.
    Yamamoto Y; Shimada S; Akiyama Y; Tsukihara S; Sugimoto R; Kabashima A; Tokunaga M; Kinugasa Y; Kawakami Y; Tanaka S
    J Gastroenterol; 2023 Jun; 58(6):540-553. PubMed ID: 36859628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune synapse formation promotes lipid peroxidation and MHC-I upregulation in licensed dendritic cells for efficient priming of CD8
    Calzada-Fraile D; Iborra S; Ramírez-Huesca M; Jorge I; Dotta E; Hernández-García E; Martín-Cófreces N; Nistal-Villán E; Veiga E; Vázquez J; Pasqual G; Sánchez-Madrid F
    Nat Commun; 2023 Oct; 14(1):6772. PubMed ID: 37880206
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.